Skip to main content

Diabetic Retinopathy Risk Peaks at a Hemoglobin A1c of 9.4, Then Declines at HIgher Levels

 

Chronic hyperglycemia causes ongoing oxidative stress and inflammation. When HbA1c exceeds 9.4%, these processes might plateau; thus, further increases in HbA1c won’t worsen them as much. This graph from the study shows the association between HbA1c and DR (red line). Blue bands represent the 95% confidence interval.

HbA1c level is known to be indicative as a critical biomarker for long-term glycemic control and is linked to risk of diabetic retinopathy development.

Researchers recently published a paper in BMC Ophthalmology in which HbA1c levels were measured and the association between this and DR was analyzed.

HbA1c positively correlated with DR; however, this was demonstrated by an inverted, U-shaped association, in which DR risk reached a peak of 9.4% with HbA1c level, then started to decline.

The authors explain that they found every 1% increase in HbA1c to be associated with a 7% increase in the odds of developing DR;

The investigators say, “Patients near the 9.4% HbA1c threshold need closer monitoring and timely intervention. For patients above 9.4%, consider aggressive glycemic control with complication monitoring.”


Ling J, Xie ZL, Chen XJ, et al. Inverted U-shaped relationship between HbA1c and diabetic retinopathy in diabetic patients: a cross-sectional study. BMC Ophthalmol. 2025;25:289.

Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH

Keratoconus and Inflammatory Skin Conditions